Events Partner Content 7th Drug Formulation, Solubility & Bioavailability Latest technologies to accelerate tme-to-market.
Partner Content Partner Content 4 KEY QUESTIONS IN NEW EXPERIMENTAL TECHNOLOGIES ANSWERED Drug Discovery Conference
Partner Content Partner Content Updates on Antibiotic Drug Resistance the medical industry n... New updates on AMR presented at Superbugs USA 2017
News Novartis joins with Berkeley to tackle "undruggable" targets Project will focus on areas such as cancer and infectious diseases
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
